These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 31659527)
1. Auger electrons for cancer therapy - a review. Ku A; Facca VJ; Cai Z; Reilly RM EJNMMI Radiopharm Chem; 2019 Oct; 4(1):27. PubMed ID: 31659527 [TBL] [Abstract][Full Text] [Related]
2. Correlation between energy deposition and molecular damage from Auger electrons: A case study of ultra-low energy (5-18 eV) electron interactions with DNA. Rezaee M; Hunting DJ; Sanche L Med Phys; 2014 Jul; 41(7):072502. PubMed ID: 24989405 [TBL] [Abstract][Full Text] [Related]
3. Radiobiological and dosimetric assessment of DNA-intercalated Belchior A; Di Maria S; Fernandes C; Vaz P; Paulo A; Raposinho P EJNMMI Res; 2020 Jul; 10(1):79. PubMed ID: 32661612 [TBL] [Abstract][Full Text] [Related]
4. Cellular lethal damage of Carrasco-Hernandez J; Ramos-Méndez J; Padilla-Rodal E; Avila-Rodriguez MA Front Med (Lausanne); 2023; 10():1253746. PubMed ID: 37841004 [TBL] [Abstract][Full Text] [Related]
5. Validation of 64Cu-ATSM damaging DNA via high-LET Auger electron emission. McMillan DD; Maeda J; Bell JJ; Genet MD; Phoonswadi G; Mann KA; Kraft SL; Kitamura H; Fujimori A; Yoshii Y; Furukawa T; Fujibayashi Y; Kato TA J Radiat Res; 2015 Sep; 56(5):784-91. PubMed ID: 26251463 [TBL] [Abstract][Full Text] [Related]
6. Absorbed dose evaluation of Auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values. Falzone N; Lee BQ; Fernández-Varea JM; Kartsonaki C; Stuchbery AE; Kibédi T; Vallis KA Phys Med Biol; 2017 Mar; 62(6):2239-2253. PubMed ID: 28102829 [TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons. Aghevlian S; Boyle AJ; Reilly RM Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852 [TBL] [Abstract][Full Text] [Related]
8. Impact of IUdR on Rat 9L glioma cell survival for 25-35 keV photon-activated auger electron therapy. Alvarez D; Hogstrom KR; Brown TA; Ii KL; Dugas JP; Ham K; Varnes ME Radiat Res; 2014 Dec; 182(6):607-17. PubMed ID: 25409122 [TBL] [Abstract][Full Text] [Related]
9. Preparation and Evaluation of Thermosensitive Liposomes Encapsulating I-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy. Elghobary MEN; Munekane M; Mishiro K; Fuchigami T; Ogawa K Molecules; 2023 Feb; 28(4):. PubMed ID: 36838851 [TBL] [Abstract][Full Text] [Related]
10. Searching for a Paradigm Shift in Auger-Electron Cancer Therapy with Tumor-Specific Radiopeptides Targeting the Mitochondria and/or the Cell Nucleus. Fernandes C; Palma E; Silva F; Belchior A; Pinto CIG; Guerreiro JF; Botelho HM; Mendes F; Raposinho P; Paulo A Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806239 [TBL] [Abstract][Full Text] [Related]
11. Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy. Bolcaen J; Gizawy MA; Terry SYA; Paulo A; Cornelissen B; Korde A; Engle J; Radchenko V; Howell RW J Nucl Med; 2023 Sep; 64(9):1344-1351. PubMed ID: 37591544 [TBL] [Abstract][Full Text] [Related]
12. PARP-1-Targeted Auger Emitters Display High-LET Cytotoxic Properties In Vitro but Show Limited Therapeutic Utility in Solid Tumor Models of Human Neuroblastoma. Lee H; Riad A; Martorano P; Mansfield A; Samanta M; Batra V; Mach RH; Maris JM; Pryma DA; Makvandi M J Nucl Med; 2020 Jun; 61(6):850-856. PubMed ID: 31676730 [TBL] [Abstract][Full Text] [Related]
14. 111In- or 99mTc-labeled recombinant VEGF bioconjugates: in vitro evaluation of their cytotoxicity on porcine aortic endothelial cells overexpressing Flt-1 receptors. Chan C; Cai Z; Su R; Reilly RM Nucl Med Biol; 2010 Feb; 37(2):105-15. PubMed ID: 20152709 [TBL] [Abstract][Full Text] [Related]
15. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape. Reilly RM; Georgiou CJ; Brown MK; Cai Z EJNMMI Radiopharm Chem; 2024 May; 9(1):37. PubMed ID: 38703297 [TBL] [Abstract][Full Text] [Related]
16. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Humm JL; Howell RW; Rao DV Med Phys; 1994 Dec; 21(12):1901-15. PubMed ID: 7700197 [TBL] [Abstract][Full Text] [Related]
17. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings. Behr TM; Béhé M; Sgouros G Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708 [TBL] [Abstract][Full Text] [Related]
18. In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([ Obata H; Tsuji AB; Sudo H; Sugyo A; Minegishi K; Nagatsu K; Ogawa M; Zhang MR Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924843 [TBL] [Abstract][Full Text] [Related]
19. Monte Carlo dose distribution calculation at nuclear level for Auger-emitting radionuclide energies. Di Maria S; Belchior A; Romanets Y; Paulo A; Vaz P Appl Radiat Isot; 2018 May; 135():72-77. PubMed ID: 29413839 [TBL] [Abstract][Full Text] [Related]
20. Low-energy electron emitters for targeted radiotherapy of small tumours. Bernhardt P; Forssell-Aronsson E; Jacobsson L; Skarnemark G Acta Oncol; 2001; 40(5):602-8. PubMed ID: 11669332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]